BDMD - Latest News
Baird Medical Investment Holdings Limited (BDMD), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $45.5M. Beta to the broader market is -1.18.
The article list below shows the most recent BDMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BDMD Headlines
Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina
prnewswire.com - Jun 29, 2026
First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, Ju
Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion
prnewswire.com - Jun 9, 2026
Enhanced U. S.
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
prnewswire.com - Apr 29, 2026
Full year 2025 revenue of $22. 5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned
How News Affects BDMD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BDMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BDMD news questions
- What is the latest BDMD news headline?
- The most recent BDMD headline (Jun 29, 2026) is "Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BDMD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BDMD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BDMD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.